Eli Lilly and Company (NYSE:LLY) Q4 2023 Earnings Call Transcript February 6, 2024 Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Lilly Q4 2023 Earnings Call. At this time all participants are in a listen-only mode. Later, we will be conducting a question-and-answer session and instructions will be given at […]
This year, I’ve been writing about how the CFO role is continuing to evolve, and talking with executives who have shared their vast experience. Yvonne McGill…
Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Lilly Q3 2023 Earnings Call. At this time all participants are in a listen-only mode [Operator Instructions].
Novo Nordisk and Eli Lilly
both expect juggernaut sales for their diabetes and
weight-loss drugs to extend into coming years - limited only by
their availability. The two companies have.